2',3'-dideoxycytidine 5'-triphosphate has been researched along with Acquired Immune Deficiency Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Betageri, GV; Black, CD; Gartner, S; Parker, RJ; Popovic, M; Szebeni, J; Wahl, LM; Wahl, SM; Weinstein, JN | 1 |
1 trial(s) available for 2',3'-dideoxycytidine 5'-triphosphate and Acquired Immune Deficiency Syndrome
Article | Year |
---|---|
Inhibition of HIV-1 in monocyte/macrophage cultures by 2',3'-dideoxycytidine-5'-triphosphate, free and in liposomes.
Topics: Acquired Immunodeficiency Syndrome; Antibodies; Antiviral Agents; Capsules; Cells, Cultured; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Deoxycytosine Nucleotides; Dideoxynucleotides; Drug Carriers; HIV-1; Humans; Immunoglobulin G; Kinetics; Liposomes; Macrophages; Monocytes; Virus Replication; Zalcitabine | 1990 |